light-attenuation-mediated photocrosslinking

Stages

1. 1.
   Gradient and microporous scaffold fabrication(library_build)

   This stage creates the physical scaffold architecture needed for controlled shape transformation while addressing transport limitations of dense hydrogels.

   Selection: Generate hydrogels with gradient network density and interconnected microporosity.

2. 2.
   Parameter tuning and physical characterization(functional_characterization)

   This stage establishes tunability and control over scaffold behavior before biological proof-of-concept testing.

   Selection: Assess how GMS content, photocrosslinking time, and construct geometry control physical and morphing properties.

3. 3.
   Cell encapsulation compatibility assessment(secondary_characterization)

   The abstract indicates that cell compatibility is needed before using the constructs for tissue formation.

   Selection: Determine whether constructs remain viable for cells and retain deformability after encapsulation.

4. 4.
   Proof-of-concept osteogenic tissue formation(confirmatory_validation)

   This stage provides the proof-of-concept biological application for the engineered scaffold platform.

   Selection: Test whether MSC-laden gradient constructs can form bone-like tissue and outperform nonporous controls on osteogenic readouts.

Steps

1. 1.
   Generate gradient network density by light-attenuation-mediated photocrosslinkinggradient-generation method

   Create a crosslink-density gradient within the hydrogel scaffold.

   The gradient network density is part of the physical basis for the internal stress mismatch that later enables shape transformation.

2. 2.
   Introduce interconnected micropores using sacrificial gelatin microspheressacrificial porogen

   Add interconnected microporosity to the scaffold.

   Microporosity is introduced during scaffold fabrication to address transport and remodeling limitations associated with dense shape-morphing hydrogels.

3. 3.
   Tune GMS content, photocrosslinking time, and construct geometryfabrication parameters and scaffold design variables

   Control microporosity, stiffness, swelling, and deformation behavior.

   Parameter tuning is used after establishing the fabrication strategy to optimize physical behavior and shape outcomes before biological testing.

4. 4.
   Assess viability and deformability after cell encapsulationcell-encapsulating scaffold

   Verify that the constructs remain compatible with cells and preserve morphing-related deformability after loading.

   This check reduces risk before longer osteogenic culture by confirming that the engineered scaffold still functions after cell encapsulation.

5. 5.
   Osteogenically differentiate MSC-laden constructs for four weeksMSC-laden scaffold under proof-of-concept application testing

   Test whether the scaffold can support bone-like tissue formation while retaining curved shape.

   This confirmatory application step follows physical and compatibility characterization to evaluate the platform in a tissue-engineering use case.

6. 6.
   Compare osteogenic readouts against nonporous controlsmicroporous gradient constructs and GMS-containing condition under comparative evaluation

   Determine whether GMS-enabled microporosity improves osteogenic outcomes relative to nonporous controls.

   The comparison is performed in the proof-of-concept application stage to test whether the porogen-enabled scaffold design yields a biological advantage.